<table className="table">
  <caption>
    <p>
      Dynamic Testing for Pituitary Dysfunction
    </p>
  </caption>
  <thead>
    <tr>
      <th colSpan="1" rowSpan="1">
        <p>
          Indication
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Test
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Technique
        </p>
      </th>
      <th colSpan="1" rowSpan="1">
        <p>
          Interpretation
        </p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td colSpan="1" rowSpan="1">
        <p>
          ACTH (cortisol) deficiency
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          ACTH stimulation test
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Measure baseline serum cortisol and ACTH levels.
        </p>
        <p>
          Administer 250 μg of synthetic ACTH IM or IV.
        </p>
        <p>
          Measure serum cortisol levels at 30 and 60 minutes.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          A peak serum cortisol level &gt;18 μg/dL (496.8 nmol/L) indicates a normal response; a lower threshold of 14 to 15 μg/dL (390-414 nmol/L) is sufficient when using newer, more specific immunoassays for measuring cortisol.
        </p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td colSpan="1" rowSpan="1">
        <p>
          AVP disorder (DI)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Water deprivation test, followed by desmopressin challenge, if indicated
          <sup>
            a
          </sup>
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Patient empties bladder, and baseline weight is measured. Start test at 8 am.
        </p>
        <p>
          Measure urine volume and osmolality hourly.
        </p>
        <p>
          Measure serum sodium, serum osmolality, and weight every 2 h.
        </p>
        <p>
          <i>
            The test is stopped after 8 h or when one of the following occurs:
          </i>
        </p>
        <p>
          Urine osmolality/serum osmolality is &gt;2
        </p>
        <p>
          Patient has lost &gt;3% of body weight
        </p>
        <p>
          Urine osmolality is stable for 2-3 h while serum osmolality rises
        </p>
        <p>
          Serum osmolality &gt;295 mOsm/kg H
          <sub>
            2
          </sub>
          O
        </p>
        <p>
          Serum sodium &gt;145 mEq/L (145 mmol/L)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          <i>
            Water deprivation test interpretation:
          </i>
        </p>
        <p>
          Urine osmolality &gt;800 mOsm/kg H
          <sub>
            2
          </sub>
          O is a normal response to water deprivation, indicating that vasopressin production and peripheral effect are intact; diagnosis is most likely primary polydipsia.
        </p>
        <p>
          Urine osmolality between 300 and 800 mOsm/kg H
          <sub>
            2
          </sub>
          O suggests partial AVP disorder.
        </p>
        <p>
          Urine osmolality &lt;300 mOsm/kg H
          <sub>
            2
          </sub>
          O is consistent with AVP disorder.
        </p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td colSpan="1" rowSpan="1">
        <p>
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          <i>
            Desmopressin challenge to differentiate between AVP resistance (nephrogenic DI) and AVP deficiency (central DI):
          </i>
        </p>
        <p>
          With serum osmolality &gt;295 mOsm/kg H
          <sub>
            2
          </sub>
          O and serum sodium &gt;145 mEq/L (145 mmol/L), give desmopressin 2 μg subcutaneously.
        </p>
        <p>
          Measure urine osmolality and urine volume hourly for 4 h after desmopressin.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          <i>
            Desmopressin challenge interpretation:
          </i>
        </p>
        <p>
          For patients with urine osmolality &lt;300 mOsm/kg H
          <sub>
            2
          </sub>
          O before desmopressin challenge:
        </p>
        <p>
          Increase in urine osmolality by &gt;50% after desmopressin is consistent with complete AVP deficiency (central DI).
        </p>
        <p>
          Increase in urine osmolality by &lt;50% indicates complete AVP resistance (nephrogenic DI).
        </p>
        <p>
          For those with urine osmolality 300-800 mOsm/kg H
          <sub>
            2
          </sub>
          O, consider partial AVP disorder.
        </p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td colSpan="1" rowSpan="1">
        <p>
          GH excess (acromegaly)
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          Glucose tolerance test
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          75-g oral glucose tolerance test. Measure plasma glucose and GH at 0, 30, 60, 90, and 120 minutes.
        </p>
      </td>
      <td colSpan="1" rowSpan="1">
        <p>
          GH &lt;0.2 ng/mL (0.2 μg/L) is a normal response.
        </p>
        <p>
          GH nadir ≥1.0 ng/mL (1.0 μg/L) (or ≥0.4 ng/mL [0.4 μg/L] on an ultrasensitive assay) is diagnostic of acromegaly.
        </p>
      </td>
    </tr>
  </tbody>
</table>
